India's drug regulator cracks down on antibiotic misuse, seeks list of licensed combinations

India's drug regulator has directed state counterparts to provide a list of antibiotic combinations licensed for manufacturing and marketing within two weeks to combat misuse. This move follows recommendations from an expert sub-committee under the Drugs Technical Authority Board (DTAB) to regulate antibiotic use. The regulator seeks to ban inappropriate combinations and monitor unapproved antibiotics in the market. A sub-committee was formed to examine this issue, leading to the recent directive to state drug regulators and port officers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sY6gSij
via IFTTT